From the Innovator's Workbench: A Tracy Lefteroff Memorial Event

Scott Gottlieb is keen observer of the promise and limitations of technology and public health. He served as the 23rd commissioner of the FDA from 2017-2019 and is currently a resident fellow at the American Enterprise Institute and a special partner at the venture capital firm New Enterprise Associates. In this conversations with David Cassak, co-editor-in-chief of MedTech Strategist, Dr. Gottlieb will share his perspective on the challenged of regulating technologies and medicines during COVID-19 and discuss implications for the development and assessment of health technologies going forward.

To Register, Visit:

  • Facebook
  • LinkedIn

© 2020 US-Japan Medtech Frontiers

USJMF Wide shot.png